Journal of Neurology Neurosurgery and Psychiatry

Journal of Neurology, Neurosurgery and Psychiatry is a monthly journal owned and published by BMJ since 1920, covering the whole of clinical neuroscience with an emphasis on common neurological and psychiatric disorders, with a 2025 Journal Impact Factor of 7.7 and a first quartile rank of 9 of 321 in surgery.《神经病学、神经外科与精神病学杂志》（Journal of Neurology Neurosurgery and Psychiatry）由（BMJ）拥有并出版，1920 年创刊，按月发行，覆盖临床神经科学全领域，尤重常见神经与精神疾病，2025 年影响因子为 7.7，在 321 种外科类期刊中列第 9 位，居第一四分位。

Scope

• Stroke is the largest single disorder covered, spanning acute care and secondary prevention.卒中是覆盖病例最多的单一疾病，涉及急性期处理与二级预防。
• Multiple sclerosis and other neuroinflammatory disease form a second major area.多发性硬化及其他神经炎性疾病构成第二个主要方向。
• Parkinson's disease and movement disorders are covered alongside epilepsy.帕金森病与运动障碍同癫痫一并收录。
• Peripheral neuropathy and neuromuscular disease are treated as core clinical subjects.周围神经病与神经肌肉疾病作为核心临床主题处理。
• Subarachnoid haemorrhage and neuropsychiatry reflect the journal's combined neurological and psychiatric remit.蛛网膜下腔出血与神经精神病学体现了该刊神经与精神并重的定位。
• Amyotrophic lateral sclerosis is named among the difficult problems the journal actively seeks.肌萎缩侧索硬化被列为该刊主动征稿的疑难问题之一。
• Papers on the broader genre of neurological sciences are accepted when they change clinical understanding.能够改变临床认识的神经科学各方向论文均在受理范围。

History

• The journal was launched in 1920 with S. A. Kinnier Wilson as founding editor.该刊于 1920 年创刊，创始主编为（S. A. Kinnier Wilson）。
• It is owned by BMJ and is the flagship of the publisher's neurology and neuroscience portfolio.该刊由（BMJ）拥有，是出版方神经病学与神经科学刊群中的旗舰刊。
• Twelve issues appear each year, under a subscription model with a hybrid open access option.该刊每年出版 12 期，采用订阅模式并提供混合开放获取选项。
• Practical Neurology, a bimonthly educational supplement, is free to subscribers of the journal.双月刊教育附刊（Practical Neurology）向本刊订户免费提供。
• Its Journal Impact Factor moved from 10.154 in 2021 to 13.654 in 2022, 7.5 in 2024 and 7.7 in 2025, with a five-year value of 9.5.该刊影响因子由 2021 年的 10.154 升至 2022 年的 13.654，2024 年为 7.5，2025 年为 7.7，五年影响因子为 9.5。
• The acceptance rate is 6 percent, and the journal states that its archive has the longest half-life of any journal in clinical neuroscience.该刊录用率为 6%，并自述其过刊的引用半衰期在临床神经科学领域最长。

Editors

• Karen L. Furie of the Warren Alpert Medical School of Brown University is editor.主编（Karen L. Furie）任职于（Warren Alpert Medical School of Brown University）。
• Nick Ward of University College London is deputy editor.副主编（Nick Ward）任职于（University College London）。
• Seven associate editors are based in the United Kingdom, Japan, the United States and Australia.七位副主编分别任职于英国、日本、美国与澳大利亚。
• A patient editorial board of three members reviews content from the patient perspective.由三位成员组成的患者编委会从患者视角审阅内容。
• Peer review is single anonymised, with reviewer names hidden from authors, and the median time to a first decision after review is 49 days.该刊采用单盲评审，审稿人姓名对作者保密，外审后首次决定中位时间为 49 天。
• The journal publishes original research, reviews and editorials, and produces podcasts on selected papers.该刊发表原创研究、综述与社论，并制作播客介绍精选论文。